Peter Lind
7Patents
7h-index
16Co-inventors
52Inventor score
Filing activity: Nov 4, 1993 → Mar 1, 1999
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6084075A | Agonist and antagonist antibodies to the chemokine receptor-2 (CCR2) | Physics | 41 | Expired |
| US6617134B1 | Dimer of molecular variant of apolipoprotein and processes for the production thereof | Emerging Cross-Sectional Technologies | 24 | Expired |
| US5876968A | Dimer of molecular variant of apolipoprotein and processes for the production thereof | Emerging Cross-Sectional Technologies | 22 | Expired |
| US5552293A | Tumor antigen specific antibody | Chemistry; Metallurgy | 20 | Expired |
| US5714503A | Compounds and methods for inhibition of HIV and related viruses | Chemistry; Metallurgy | 18 | Expired |
| US5658907A | Compounds and methods for inhibition of HIV and related viruses | Chemistry; Metallurgy | 17 | Expired |
| US6001578A | Methods of screening for modulators of uncoupling protein-2 (UCP-2) as potential treatments for obesity | Emerging Cross-Sectional Technologies | 7 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.